Sonographic Assessment and Visualization of Ectopics in Emergency Medicine

Learn more about:
Related Clinical Trial
Medical Treatment in Ectopic Tubal Pregnancy Evaluation of Different Doses of Letrozole in Ectopic Pregnancy Evaluation of Ipsilateral Tubal Patency After Conservative Medical or Surgical Treatment. Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task Expectant Management of Ectopic Pregnancy Psychological Impact of Pregnancy of Unknown Location Assessment of Biomarkers in Pregnancy on Unknown Location and Ectopic Pregnancy Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus Cornual Wedge Resection Outcome Pregnancies of Uncertain Location or Viability Research Randomized Population-Based Study on Chlamydia Trachomatis Screening Sonographic Assessment and Visualization of Ectopics in Emergency Medicine Kisspeptin Levels in Early Pregnancy RCT for Women With a Persisting Pregnancy of Unknown Location Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location Activin A and Inhibin A in Predicting Outcome of Pregnancies of Unknown Location After Assisted Reproductive Technology Evaluation of the Axonemal Dynein Heavy Chain 5 and Creatine Kinase Concentration in Cervical Fluid for Early Detection of the Ectopic Pregnancy Vitamin D in Ectopic Pregnancies Laparoscopic Tubal Preservation Surgery BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success The Correlation Between Uterine Endometrial Pattern and Ectopic Pregnancy Adnexal Mass After Methotrexate Treatment for Ectopic Pregnancies The Impact of Salpingectomy and Single Dose Systemic Methotrexate Treatments on Ovarian Reserve in Ectopic Pregnancy Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy Methotrexate Treatment for Ectopic Pregnancy Comparison of Two Different Approaches in the Surgical Treatment of Tubal Ectopic Pregnancy Two-Dose Methotrexate for Ectopic Pregnancy Ectopic Pregnancy Biomarkers The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy Are Serum Levels of Vascular Endothelial Growth Factor a Marker for the Early Diagnosis of Ectopic Pregnancy? Risk Factors of Ectopic Pregnancy Assessment of Biomarkers in Ectopic Pregnancy Risk of Ectopic Pregnancy and Variation of Luteal Estradiol and Progesterone Levels in IVF

Brief Title

Sonographic Assessment and Visualization of Ectopics in Emergency Medicine

Official Title

Sonographic Assessment and Visualization of Ectopics in Emergency Medicine (SAVE'EM)

Brief Summary

      Observational study of the use of ultrasound by emergency physicians in the evaluation of
      patients at risk of ectopic pregnancy.

Detailed Description

      Emergency Physicians who have undergone training according to the American College of
      Emergency Physicians Guidelines will be evaluated in the accuracy of performing pelvic
      ultrasounds among patients at risk for ectopic pregnancy.

Study Type


Primary Outcome

Clinical outcome of the pregnancy


Ectopic Pregnancy


Pelvic Ultrasound

Study Arms / Comparison Groups

 At Risk of Ectopic Pregnancy
Description:  Women who present to the emergency department at UCSF who are at risk of ectopic pregnancy.


* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status


Estimated Enrollment


Start Date

February 2007

Completion Date

June 2013

Primary Completion Date

June 2013

Eligibility Criteria

        Inclusion Criteria:

          -  pregnant females in 1st trimester

          -  present to emergency department

          -  complaint of abdominal/pelvic pain or vaginal bleeding

        Exclusion Criteria:

          -  previous ultrasound diagnostic of location of pregnancy




12 Years - 55 Years

Accepts Healthy Volunteers



John C. Stein, M.D., , 

Location Countries

United States

Location Countries

United States

Administrative Informations



Organization ID


Responsible Party


Study Sponsor

University of California, San Francisco


 Agency for Healthcare Research and Quality (AHRQ)

Study Sponsor

John C. Stein, M.D., Principal Investigator, University of California, San Francisco

Verification Date

January 2014